Cargando…
Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic
Rituximab is a mouse/human chimeric monoclonal antibody targeted toward CD20. It is efficient as first-line therapy of CD20-positive B-cell malignancies. However, a large fraction of treated patients relapse with rituximab-resistant disease. So far, only modest progress has been made in treatment op...
Autores principales: | Richter, Maximilian, Yumul, Roma, Saydaminova, Kamola, Wang, Hongjie, Gough, Michael, Baldessari, Audrey, Cattaneo, Roberto, Lee, Frank, Wang, Chung-Huei Katherine, Jang, Haishan, Astier, Anne, Gopal, Ajay, Carter, Darrick, Lieber, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813608/ https://www.ncbi.nlm.nih.gov/pubmed/27069950 http://dx.doi.org/10.1038/mtm.2016.13 |
Ejemplares similares
-
Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin
por: Richter, Maximilian, et al.
Publicado: (2015) -
Role of Cellular Heparan Sulfate Proteoglycans in Infection of Human Adenovirus Serotype 3 and 35
por: Tuve, Sebastian, et al.
Publicado: (2008) -
Quantification of designer nuclease induced mutation rates: a direct comparison of different methods
por: Ehrke-Schulz, Eric, et al.
Publicado: (2016) -
Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation
por: Saydaminova, Kamola, et al.
Publicado: (2015) -
A multidimensional metabolomics workflow to image biodistribution and evaluate pharmacodynamics in adult zebrafish
por: Jackstadt, Madelyn M., et al.
Publicado: (2022)